Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
g decrease » _ decrease (Expand Search), gy decreased (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 g » 5 mg (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
g decrease » _ decrease (Expand Search), gy decreased (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 g » 5 mg (Expand Search)
-
721
CDK5 knockdown increases TP53 and p27<sup>Kip1</sup> protein half-lives, increases nuclear localization of the two proteins, decreases p27<sup>Kip1</sup> p-T187 phosphorylation and induces p21<sup>Cip1</sup> in a TP53-dependent manner.
Published 2015“…<p>(<b>A</b>) Transfection with CDK5 siRNA increased the half-life of p53 and p27<sup>Kip1</sup> protein. …”
-
722
-
723
-
724
-
725
-
726
-
727
-
728
-
729
-
730
Table_5_Decrease of Clone Diversity in IgM Repertoires of HBV Chronically Infected Individuals With High Level of Viral Replication.pdf
Published 2021“…To investigate the characteristics of antibody repertoires in patients with chronic HBV infection, we performed Illumina sequencing and IMGT/HighV-QUEST analysis of B lymphocytes from healthy adults and the HBV carriers with high or low level of viral replication. …”
-
731
Positive modulation of mGluR5 decreases spine density in the nucleus accumbens but not in the dorsal striatum.
Published 2016“…<p>(A) Twenty-four hours after systemic administration, CDPPB (5–10 mg/kg, <i>n</i> = 18 animals) decreased dendritic spine density and frequency of small head diameter spines (0.2 μm bin) compared to vehicle control (<i>n</i> = 8) in the nucleus accumbens core. …”
-
732
OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts.
Published 2019“…Treatment with Gemcitabine or Cisplatin alone decreased tumor volume to a higher (p < 0.05) extent than OCA alone. …”
-
733
-
734
-
735
-
736
-
737
-
738
Decreased s.c. growth of CNDT 2.5 cells after systemic administration of DOPC liposome-conjugated siNRP-2.
Published 2013“…NRP-2-siRNA DOPC-treatment led to a significant decrease in tumor growth compared with cntr siRNA DOPC-treatment (264.4 mm<sup>3</sup> vs. 751.3 mm<sup>3</sup>, respectively; *<i>p</i> = 0.01). …”
-
739
-
740